Takotsubo syndrome, also known as “broken heart syndrome,” is a transient heart condition that predominantly affects postmenopausal women and can be triggered by severe emotional or physical stress. It accounts for approximately 2% of patients initially suspected of having a heart attack and up to 10% of women with acute coronary syndrome. The syndrome presents with symptoms such as chest pain, abnormal electrocardiogram results, and elevated cardiac enzymes, which closely mimic those of a heart attack. However, unlike a heart attack, Takotsubo syndrome does not involve blocked coronary arteries, making it challenging to differentiate between the two conditions during initial evaluation, often necessitating invasive cardiac catheterization for accurate diagnosis.

To address this diagnostic challenge, an international team of researchers, in collaboration with scientists from the universities of Zurich and Greifswald, has developed and validated a diagnostic scoring system called the BioTAK score. This tool combines biological sex with several blood biomarkers associated with various cardiovascular processes. Utilizing artificial intelligence, the researchers identified the most informative combination of biomarkers and integrated them into a clinical decision tool. In an independent validation study involving nearly 1,800 patients, the BioTAK score demonstrated high accuracy in identifying Takotsubo syndrome before cardiac catheterization, correctly classifying nearly 90% of participants. The score not only aids in diagnosis but also provides insights into the distinct biological mechanisms underlying Takotsubo syndrome compared to a classic heart attack. Source

This is a summary. Read the original at sciencedaily.com.